Shopping Cart
Remove All
Your shopping cart is currently empty
G3335 Acetate was discovered to be a novel PPARgamma antagonist.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $50 | In Stock | In Stock | |
| 10 mg | $75 | In Stock | In Stock | |
| 25 mg | $128 | In Stock | In Stock | |
| 50 mg | $192 | In Stock | In Stock | |
| 100 mg | $287 | In Stock | In Stock | |
| 200 mg | $431 | In Stock | In Stock | |
| 500 mg | $713 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $72 | In Stock | In Stock |
| Description | G3335 Acetate was discovered to be a novel PPARgamma antagonist. |
| Targets&IC50 | PPARγ:8.34 μM(kd), PPARγ:8.67 μM(kd) |
| In vitro | G3335 exhibits a highly specific binding affinity against PPARgamma (K(D) = 8.34 microM) and is able to block rosiglitazone, a potent PPARgamma agonist, in the stimulation of the interaction between the PPARgamma ligand-binding domain (LBD) and RXRalpha-LBD. Yeast two-hybrid assays demonstrated that G3335 exhibits strong antagonistic activity (IC50 = 8.67 microM) in perturbing rosiglitazone in the promotion of the PPARgamma-LBD-CBP interaction. |
| Synonyms | G3335 Acetate (36099-95-3 free base) |
| Molecular Weight | 393.39 |
| Formula | C18H23N3O7 |
| Smiles | OC(CC[C@H](NC([C@H](CC1=CNC2=C1C=CC=C2)N)=O)C(O)=O)=O.CC(O)=O |
| Relative Density. | no data available |
| Sequence | H-Trp-Glu-OH |
| Sequence Short | WE |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 55 mg/mL (139.81 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.